AUGUST S. BASSANI, PHARM.D.

Corporate Board Profile

Tech Score: 0/100

HARROW, INC.

Filing Date	Source Excerpt
2013-09-12	On December 14, 2012, in connection with his appointment as a director, the Board of Directors granted to Mr. Bassani an option to purchase up to 7,603 shares of our common stock under the Plan. That option has an exercise price of $10.75 per share, has a term of five years, and vests monthly over a period of one year commencing on January 1, 2013.
2014-08-08	August (“Gus”) S. Bassani, Pharm.D. has served as a director since December 2012. He currently serves as Vice-President of Consulting, R&D and Formulations at PCCA and has been with PCCA since September 2002. Prior to joining PCCA, Mr. Bassani was a formulation pharmacist for a veterinary pharmaceutical company and worked in multiple pharmacy practice settings. Mr. Bassani has taught extemporaneous compounding principles to pharmacy students at Drake University. Mr. Bassani received his Doctor of Pharmacy degree from Drake University College of Pharmacy and Health Sciences. He is a member of the 2010 – 2015 United States Pharmacopeia (USP) Council of Experts – Compounding Expert Committee, and is serving on the 2012 – 2014 Drake University College of Pharmacy and Health Sciences National Advisory Council. He is a member of the American Pharmacists Association, International Academy of Compounding Pharmacists, American Society of Health Systems Pharmacists and the American Association of Pharmaceutical Scientists. Mr. Bassani’s widespread experience in the pharmaceutical industry and his formulation expertise provides valued guidance to our management and board.

Filing Date

Source Excerpt

2013-09-12

On December 14, 2012, in connection with his appointment as a director, the Board of Directors granted to Mr. Bassani an option to purchase up to 7,603 shares of our common stock under the Plan. That option has an exercise price of $10.75 per share, has a term of five years, and vests monthly over a period of one year commencing on January 1, 2013.

2014-08-08

August (“Gus”) S. Bassani, Pharm.D. has served as a director since December 2012. He currently serves as Vice-President of Consulting, R&D and Formulations at PCCA and has been with PCCA since September 2002. Prior to joining PCCA, Mr. Bassani was a formulation pharmacist for a veterinary pharmaceutical company and worked in multiple pharmacy practice settings. Mr. Bassani has taught extemporaneous compounding principles to pharmacy students at Drake University. Mr. Bassani received his Doctor of Pharmacy degree from Drake University College of Pharmacy and Health Sciences. He is a member of the 2010 – 2015 United States Pharmacopeia (USP) Council of Experts – Compounding Expert Committee, and is serving on the 2012 – 2014 Drake University College of Pharmacy and Health Sciences National Advisory Council. He is a member of the American Pharmacists Association, International Academy of Compounding Pharmacists, American Society of Health Systems Pharmacists and the American Association of Pharmaceutical Scientists. Mr. Bassani’s widespread experience in the pharmaceutical industry and his formulation expertise provides valued guidance to our management and board.

Data sourced from SEC filings. Last updated: 2026-03-14